ECHA’s Member State Committee has recently confirmed that a combined in vivo comet assay (OECD 489) and micronucleus test (OECD 474) will be considered as one study for regulatory purposes. This can help to reduce animal testing and testing costs, when substances cause concern for both gene mutation and chromosomal damage from in vitro tests.